SCHEMBL20137432

SCHEMBL20137432

NC1(CC(=O)O)CCCc2cnccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 4/20 0.38
KDM5A P29375 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
CHRM2 P08172 2/20 0.35
CHRM3 P20309 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CHRM1 P11229 1/20 0.35
SLC22A12 Q96S37 2/20 0.35
GRM4 Q14833 2/20 0.35
F2 P00734 2/20 0.35
CHRM4 P08173 1/20 0.34
RAD52 P43351 1/20 0.34
ROCK2 O75116 1/20 0.33
GRK2 P25098 1/20 0.33
HSD11B1 P28845 1/20 0.33
KDM1A O60341 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
KDM6B O15054 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28483551 1.00 KDM4C (0.38) KDM4CKDM5AKDM5BSIGMAR1CHRM2
SCHEMBL28478058 0.89 KDM4C (0.41) KDM4CKDM5AKDM5BSIGMAR1CHRM2
SCHEMBL28478061 0.89 KDM4C (0.41) KDM4CKDM5AKDM5BSIGMAR1CHRM2
SCHEMBL28476884 0.84 KDM4C (0.38) KDM4CKDM5AKDM5BSIGMAR1CHRM2
SCHEMBL28476883 0.84 KDM4C (0.38) KDM4CKDM5AKDM5BSIGMAR1CHRM2
SCHEMBL30995682 0.84 KDM4C (0.38) KDM4CKDM5AKDM5BSIGMAR1CHRM2
SCHEMBL20137423 0.80 KDM1A (0.46) SIGMAR1RAD52KDM1AMEN1KMT2A
SCHEMBL28901494 0.80 KDM1A (0.46) SIGMAR1RAD52KDM1AMEN1KMT2A
SCHEMBL30995685 0.74 KDM4C (0.40) KDM4CKDM5AKDM5BSIGMAR1ALDH1A1
SCHEMBL28486636 0.74 KDM4C (0.40) KDM4CKDM5AKDM5BSIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12006323-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2024-06-11 US disclosed
US-11034699-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2021-06-15 US disclosed
CN-107580598-B Ethynyl derivatives as metabotropic glutamate receptor modulators 豪夫迈·罗氏有限公司 2020-11-13 CN disclosed
EP-3322701-B1 ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS HOFFMANN LA ROCHE (CH) 2019-05-01 EP disclosed
US-20190119290-A1 ETHYNYL DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2019-04-25 US disclosed
US-10189848-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2019-01-29 US disclosed
US-20180134721-A1 ETHYNYL DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034699-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM4C 3493/4885KDM5A 3934/4885KDM5B 3781/4885
US-20180134721-A1 ETHYNYL DERIVATIVES GRM4, GRM2, GRIA4 KDM4C 3493/4885KDM5A 3934/4885KDM5B 3781/4885
US-20190119290-A1 ETHYNYL DERIVATIVES GRM4, GRM2, GRIA4 KDM4C 3493/4885KDM5A 3934/4885KDM5B 3781/4885
US-12006323-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM4C 3493/4885KDM5A 3934/4885KDM5B 3781/4885
US-10189848-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM4C 3493/4885KDM5A 3934/4885KDM5B 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.